Who Owns Cellectar Biosciences Stock?
NASDAQ: CLRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 1:45 PM ET
Ownership breakdown
- Held by institutions
- 34.71%
- Held by insiders
- 1.75%
- Institutional holders
- 33
- Institutions 34.7%
- Insiders 1.8%
- Public and other 63.5%
Who owns Cellectar Biosciences stock?
Institutional investors own about 34.7% of Cellectar Biosciences's shares, spread across 33 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.75% of CLRB.
The largest institutional holders are Caligan Partners, LP (4.97%), Stempoint Capital LP (3.76%) and Vanguard Capital Management LLC (3.46%). Together, the top 10 institutions control 29.7% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their CLRB positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CLRB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Caligan Partners, LP | 470.00K | 4.97% | +100.0% |
| Stempoint Capital LP | 354.94K | 3.76% | +100.0% |
| Vanguard Capital Management LLC | 327.37K | 3.46% | +299.8% |
| SilverArc Capital Management, LLC | 321.73K | 3.40% | +100.0% |
| Bleichroeder LP | 288.68K | 3.05% | +188.7% |
| Jupiter Topco LLC | 274.16K | 2.90% | +100.0% |
| Balyasny Asset Management LP | 220.00K | 2.33% | +100.0% |
| Nantahala Capital Management, LLC | 220.00K | 2.33% | +100.0% |
| Empery Asset Management, LP | 189.60K | 2.01% | +100.0% |
| Diadema Partners LP | 138.34K | 1.46% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CLRB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 184.15K | 1.95% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 143.22K | 1.52% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 42.52K | 0.45% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 5.64K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 2.06K | 0.02% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 1 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Cellectar Biosciences?
Caligan Partners, LP is the largest institutional shareholder of CLRB, owning 4.97% of shares outstanding (470.00K shares) as of its latest 13F filing.
What percentage of Cellectar Biosciences is owned by institutions?
Institutions own about 34.7% of CLRB shares and 35.3% of the public float.
How much of Cellectar Biosciences do insiders own?
Insiders, such as officers and directors, own about 1.75% of CLRB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.